JP2024516392A5 - - Google Patents
Info
- Publication number
- JP2024516392A5 JP2024516392A5 JP2023565419A JP2023565419A JP2024516392A5 JP 2024516392 A5 JP2024516392 A5 JP 2024516392A5 JP 2023565419 A JP2023565419 A JP 2023565419A JP 2023565419 A JP2023565419 A JP 2023565419A JP 2024516392 A5 JP2024516392 A5 JP 2024516392A5
- Authority
- JP
- Japan
- Prior art keywords
- igg
- human
- molecule
- oligomer
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163180969P | 2021-04-28 | 2021-04-28 | |
| US63/180,969 | 2021-04-28 | ||
| PCT/US2022/026505 WO2022232246A1 (en) | 2021-04-28 | 2022-04-27 | Multimerization of binding molecules having an antibody constant region variant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516392A JP2024516392A (ja) | 2024-04-15 |
| JP2024516392A5 true JP2024516392A5 (cg-RX-API-DMAC10.html) | 2025-05-02 |
Family
ID=83847261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565419A Withdrawn JP2024516392A (ja) | 2021-04-28 | 2022-04-27 | 抗体定常領域バリアントを有する結合分子の多量体化 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240209116A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4330277A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024516392A (cg-RX-API-DMAC10.html) |
| CN (2) | CN118359707A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022266780A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3216755A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022232246A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022045865A1 (ko) * | 2020-08-31 | 2022-03-03 | (주)메디톡스 | 항-vegf 육량체 항체, 및 이를 포함하는 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014MN02293A (cg-RX-API-DMAC10.html) * | 2012-04-20 | 2015-08-07 | Emergent Product Dev Seattle | |
| WO2014006217A1 (en) * | 2012-07-06 | 2014-01-09 | Genmab B.V. | Dimeric protein with triple mutations |
| CA2879814A1 (en) * | 2012-08-02 | 2014-02-06 | Jn Biosciences Llc | Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece |
| ES2719584T3 (es) * | 2014-04-11 | 2019-07-11 | Medimmune Llc | Compuestos conjugados que comprenden anticuerpos modificados por ingeniería genética con cisteína |
| MX2017012805A (es) * | 2015-04-07 | 2018-04-11 | Genentech Inc | Complejo de unión a antígenos con actividad agonista y métodos de uso. |
-
2022
- 2022-04-27 WO PCT/US2022/026505 patent/WO2022232246A1/en not_active Ceased
- 2022-04-27 JP JP2023565419A patent/JP2024516392A/ja not_active Withdrawn
- 2022-04-27 EP EP22796621.5A patent/EP4330277A4/en not_active Withdrawn
- 2022-04-27 AU AU2022266780A patent/AU2022266780A1/en not_active Abandoned
- 2022-04-27 CN CN202410422718.3A patent/CN118359707A/zh active Pending
- 2022-04-27 CN CN202280030416.0A patent/CN117255800A/zh active Pending
- 2022-04-27 US US18/557,273 patent/US20240209116A1/en active Pending
- 2022-04-27 CA CA3216755A patent/CA3216755A1/en active Pending